Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects

Clinical trial NCT01342796 · COMPLETED

Trial details

NCT number: NCT01342796
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Seasonal Influenza Influenza Influenza Due to Unspecified Influenza Virus Human Influenza

Start date: 2011-05-01
Primary completion: 2012-02-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.